Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Semaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Tirzepatide and semaglutide are both type 2 diabetes medications that can also assist people with weight loss. Results from a recent study suggest that tirzepatide may be more effective in helping ...

Explore how to optimize your diet while on weight loss drugs like semaglutide and tirzepatide. Learn about the best foods to eat, those to avoid, and the importance of hydration and macronutrients.

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their prescribed obesity medication, according to findings published in Obesity.

At the time of the analysis, tirzepatide wasn't yet approved for a chronic weight management indication, which it received in November 2023.A higher dosage of semaglutide (2.4 mg) was approved for ...